Knoll Capital Management’s Corbus Pharmaceuticals CRBP Stock Holding History

Knoll Capital Management’s Portfolio CRBP Stock Details CRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-168,196	Closed	-$833K	–	27
2022 Q3	$833K	Hold	168,196	–	–	0.49%	14
2022 Q2	$1.27M	Hold	168,196	–	–	0.73%	11
2022 Q1	$2.68M	Hold	168,196	–	–	1.68%	6
2021 Q4	$3.11M	Hold	168,196	–	–	1.71%	7
2021 Q3	$5.15M	Hold	168,196	–	–	2.57%	5
2021 Q2	$9.23M	Hold	168,196	–	–	4.82%	4
2021 Q1	$9.94M	Hold	168,196	–	–	6.48%	3
2020 Q4	$6.31M	Hold	168,196	–	–	4.3%	4
2020 Q3	$9.08M	Hold	168,196	–	–	7.44%	3
2020 Q2	$42.3M	Hold	168,196	–	–	24.44%	2
2020 Q1	$26.4M	Hold	168,196	–	–	24.84%	2
2019 Q4	$27.6M	Buy	168,196 +2,000	+1%	+$296K	20.34%	2
2019 Q3	$24.3M	Hold	166,196	–	–	22.22%	2
2019 Q2	$34.6M	Hold	166,196	–	–	28.29%	1
2019 Q1	$34.7M	Buy	166,196 +30,770	+23%	+$6.79M	26.33%	2
2018 Q4	$23.7M	Hold	135,426	–	–	26.99%	2
2018 Q3	$30.5M	Buy	135,426 +4,964	+4%	+$803K	25.76%	1
2018 Q2	$19.8M	Buy	130,462 +1,896	+1%	+$344K	16.8%	3
2018 Q1	$23.5M	Hold	128,566	–	–	24.16%	2
2017 Q4	$27.4M	Buy	128,566 +3,935	+3%	+$842K	24.14%	2
2017 Q3	$26.7M	Hold	124,631	–	–	22.86%	3
2017 Q2	$23.6M	Hold	124,631	–	–	31.23%	1
2017 Q1	$30.8M	Buy	124,631 +39,167	+46%	+$9.61M	46.51%	1
2016 Q4	$21.7M	Hold	85,464	–	–	38.01%	1
2016 Q3	$16.7M	Hold	85,464	–	–	29.31%	1
2016 Q2	$7.67M	Hold	85,464	–	–	2.48%	2
2016 Q1	$4.64M	Hold	85,464	–	–	1.88%	4
2015 Q4	$4.23M	Sell	85,464 -6,203	-7%	-$316K	1.57%	7
2015 Q3	$4.33M	Buy	91,667 +33,334	+57%	+$2.22M	1.84%	6
2015 Q2	$5.39M	Buy	+58,333	New	+$5.87M	1.74%	7

Other funds holding CRBP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Knoll Capital Management's CRBP Position: Q4 2022 in Review

Knoll Capital Management sold out of Corbus Pharmaceuticals (CRBP) in Q4 2022, closing a stake of 168,196 shares — an estimated $833K sold.

Knoll Capital Management first reported a position in CRBP in Q2 2015 and held it in 30 quarters. The position peaked at $42.3M in Q2 2020. 63 funds tracked by Wall St. Rank hold CRBP as of Q4 2022.

Knoll Capital Management reported no remaining Corbus Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Knoll Capital Management sold 168,196 Corbus Pharmaceuticals shares in Q4 2022, an estimated $833K.
Knoll Capital Management first reported a position in Corbus Pharmaceuticals in Q2 2015 and held it in 30 quarters.
Knoll Capital Management's Corbus Pharmaceuticals position peaked at $42.3M in Q2 2020.
63 funds tracked by Wall St. Rank held Corbus Pharmaceuticals as of Q4 2022.

Based on Knoll Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.